Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17952209 | 0.86 | CYP1A2 (0.33) | ALDH1A1MEN1KMT2APOLBTSHR | |
| SCHEMBL17952220 | 0.81 | MGLL (0.37) | ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A | |
| SCHEMBL17952170 | 0.81 | ALDH1A1 (0.33) | ALDH1A1SMN1; SMN2KDM4EGRIA2GRIA4 | |
| SCHEMBL17952197 | 0.78 | GRIA2 (0.34) | ALDH1A1SMN1; SMN2KDM4EGRIA2GRIA4 | |
| SCHEMBL17952171 | 0.76 | KMT2A (0.37) | ALDH1A1SMN1; SMN2KDM4EL3MBTL1MEN1 | |
| SCHEMBL17952269 | 0.76 | AR (0.35) | ALDH1A1SMN1; SMN2KDM4EGRIA2GRIA4 | |
| SCHEMBL17952219 | 0.74 | USP30 (0.33) | ALDH1A1KDM4EGRIA2GRIA4 | |
| SCHEMBL17952189 | 0.74 | CYP1A2 (0.38) | ALDH1A1KDM4ETDP1L3MBTL1MEN1 | |
| SCHEMBL17947419 | 0.74 | SMN1; SMN2 (0.37) | ALDH1A1SMN1; SMN2KDM4EHPGDTSHR | |
| SCHEMBL17952527 | 0.74 | SMN1; SMN2 (0.37) | ALDH1A1SMN1; SMN2KDM4EHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-17 | — | — | US | disclosed |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2016-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10418569-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, OSBP2 | ALDH1A1 1620/4885SMN1; SMN2 3820/4885KDM4E 4426/4885 |
| US-20160218303-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | ALDH1A1 1620/4885SMN1; SMN2 3820/4885KDM4E 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.